Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,909 | 7,410 | 15,402 | 21,837 | 28,756 |
| Receivables | 15 | N/A | 8 | N/A | 1,000 |
| TOTAL | $6,848 | $8,712 | $17,236 | $23,801 | $31,266 |
| Non-Current Assets | |||||
| PPE Net | 5 | 21 | 24 | 22 | 17 |
| TOTAL | $5 | $21 | $24 | $22 | $17 |
| Total Assets | $6,853 | $8,733 | $17,260 | $23,823 | $31,283 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 526 | 472 | 1,226 | 486 | 714 |
| Accrued Expenses | 1,205 | 2,487 | 3,255 | 2,477 | 3,088 |
| Other current liabilities | 518 | 523 | 235 | 809 | 1,946 |
| TOTAL | $2,249 | $3,482 | $4,716 | $3,772 | $5,748 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,249 | $3,482 | $4,716 | $3,772 | $5,748 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,717 | 9,496 | 9,496 | 9,046 | 8,614 |
| Common Shares | 98 | 96 | 91 | 87 | 87 |
| Retained earnings | -591,606 | -590,843 | -583,491 | -575,425 | -569,228 |
| Other shareholders' equity | 31,208 | 26,681 | 22,154 | 17,626 | 17,627 |
| TOTAL | $4,604 | $5,251 | $12,544 | $20,051 | $25,535 |
| Total Liabilities And Equity | $6,853 | $8,733 | $17,260 | $23,823 | $31,283 |